RY 152.64 -0.722% TD 79.42 -0.3638% SHOP 86.76 0.2311% CNR 165.66 -0.2529% ENB 50.17 0.8645% CP 114.78 0.4463% BMO 119.46 0.395% TRI 223.44 -0.1118% CNQ 48.32 -1.2265% BN 63.27 -0.1263% ATD 82.05 -0.231% CSU 4214.73 0.4019% BNS 64.16 -1.1707% CM 68.67 0.0146% SU 52.85 -0.7139% TRP 56.41 2.0441% NGT 64.6 -0.9202% WCN 247.72 -0.394% MFC 35.62 -0.6138% BCE 45.62 -0.2405%

Aurora Spine Corp

Healthcare CA ASG

0.28CAD
-(-%)

Last update at 2024-07-19T13:30:00Z

Day Range

0.280.28
LowHigh

52 Week Range

0.230.47
LowHigh

Fundamentals

  • Previous Close 0.28
  • Market Cap25.73M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.20822M
  • Revenue TTM14.09M
  • Revenue Per Share TTM0.20
  • Gross Profit TTM 4.83M
  • Diluted EPS TTM-0.04

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Minority interest - - - - -
Net income -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Selling general administrative 7.12M 5.79M 3.76M 4.03M 3.68M
Selling and marketing expenses - - - - -
Gross profit 7.81M 4.83M 3.47M 3.55M 4.59M
Reconciled depreciation 0.87M 0.65M 0.59M 0.39M 0.78M
Ebit - -2.55037M -1.16340M -1.07948M 0.09M
Ebitda -0.46927M -1.90168M -0.57386M -0.69361M 0.86M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.34341M -2.55037M -1.16340M -1.07948M 0.09M
Other operating expenses - - - - -
Interest expense 0.16M 0.00000M 0.00000M 0.17M 0.15M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.16360M -0.15910M -0.08771M -0.17401M -0.14758M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 14.88M 10.54M 8.65M 11.15M 8.68M
Total operating expenses 16.22M 13.10M 9.81M 12.23M 8.59M
Cost of revenue 7.07M 5.71M 5.18M 7.61M 4.09M
Total other income expense net 0.00554M 0.35M 1.02M -0.00078M -0.01205M
Discontinued operations - - - - -
Net income from continuing ops -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Net income applicable to common shares - -2.35933M -0.23209M -1.25427M -0.06820M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 10.12M 10.56M 7.16M 6.67M 6.84M
Intangible assets 0.88M 0.85M 0.87M 0.84M 0.85M
Earning assets - - - - -
Other current assets - - - - -
Total liab 5.81M 4.99M 3.87M 4.91M 3.88M
Total stockholder equity 4.32M 5.57M 3.28M 1.77M 2.96M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - 25.09M 22.01M 20.67M 20.66M
Capital stock 25.22M 25.09M 22.01M 20.67M 20.66M
Retained earnings -24.09472M -22.59325M -20.23393M -20.00184M -18.71420M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.42M 3.17M 1.71M 0.44M 0.86M
Cash and equivalents - - - - -
Total current liabilities 3.03M 2.63M 1.56M 2.52M 1.90M
Current deferred revenue - - - - -
Net debt 1.99M - 0.46M 1.69M 1.16M
Short term debt - - - - -
Short long term debt - 0.01M 0.03M 0.03M -
Short long term debt total - - - - -
Other stockholder equity - 3.08M 1.51M 1.10M 1.01M
Property plant equipment - 1.30M 1.09M 1.16M 0.77M
Total current assets 7.33M 8.41M 5.20M 4.68M 5.22M
Long term investments - - - - -
Net tangible assets - 4.71M 2.41M 0.93M 2.10M
Short term investments - - - - -
Net receivables 3.67M 2.67M 1.66M 2.44M 1.58M
Long term debt 2.42M 2.27M 2.14M 2.10M 2.02M
Inventory 3.05M 1.89M 1.60M 1.53M 2.56M
Accounts payable 2.83M 2.45M 1.53M 2.49M 1.87M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 1.62M
Deferred long term asset charges - - - - -
Non current assets total 2.79M 2.16M 1.96M 1.99M 1.62M
Capital lease obligations 0.55M 0.09M 0.17M 0.28M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.87321M -0.72061M -0.55464M -0.28387M -0.27888M
Change to liabilities - 1.04M -0.40360M 0.50M 0.13M
Total cashflows from investing activities - -0.72061M -0.55464M -0.28387M -0.27888M
Net borrowings - -0.19349M -0.14207M -0.13362M -0.03000M
Total cash from financing activities -0.31815M 4.31M 1.51M -0.12862M 0.69M
Change to operating activities - -0.44343M 0.03M -0.04292M 0.25M
Net income -1.50147M -2.35933M -0.23209M -1.25427M -0.06820M
Change in cash -2.74917M 1.46M 1.27M -0.41176M 0.84M
Begin period cash flow 3.17M 1.71M 0.44M 0.86M 0.01M
End period cash flow 0.42M 3.17M 1.71M 0.44M 0.86M
Total cash from operating activities -1.55782M -2.12935M 0.31M 0.00073M 0.44M
Issuance of capital stock 0.00000M 5.12M 1.70M 0.00500M 0.74M
Depreciation 0.87M 0.65M 0.59M 0.39M 0.78M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -1.16453M -0.33360M -0.31589M 0.10M -0.10045M
Change to account receivables - -1.01005M 0.78M -0.85883M -0.77278M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.88M 0.27M 0.27M -0.02427M
Change to netincome - 0.33M -0.14433M 1.17M 0.21M
Capital expenditures 0.87M 0.72M 0.51M 0.29M 0.29M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.35888M -0.74449M 0.10M -0.29899M -0.48682M
Stock based compensation 0.14M 0.14M 0.09M 0.09M -
Other non cash items 0.23M 0.14M -0.48615M 0.14M 0.14M
Free cash flow -2.43102M -2.84996M -0.24507M -0.28599M 0.14M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ASG
Aurora Spine Corp
- -% 0.28 - - 1.83 5.11 2.14 -31.4665
PINK
Perimeter Medical Imaging AI Inc
-0.025 4.81% 0.49 - - 117.72 2.89 122.12 -4.2252
VPT
VentriPoint Diagnostics Ltd
- -% 0.20 - - 1376.49 34.01 1193.16 -9.1712
TLT
Theralase Technologies Inc.
- -% 0.17 - - 35.41 23.10 36.69 -9.1528
NGMD
NuGen Medical Devices Inc
- -% 0.14 - - 107.75 9.71 118.72 -4.5025

Reports Covered

Stock Research & News

Profile

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L spinal fusion system. Aurora Spine Corporation was founded in 2013 and is headquartered in Toronto, Canada.

Aurora Spine Corp

20 Holly Street, Toronto, ON, Canada, M4S 3B1

Key Executives

Name Title Year Born
Mr. Trent J. Northcutt Founder, Pres, CEO & Director 1967
Mr. Chad Clouse Chief Financial Officer NA
Mr. Laszlo Garamszegi CTO & Founder 1971
Mr. David M. Meyer VP, Chief Legal Officer & Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.